ArticleOncotarget2017

Targeting PEPT1: a novel strategy to improve the antitumor efficacy of doxorubicin in human hepatocellular carcinoma therapy.

Yanxia Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.